Myeloid-derived-suppressor cells as regulators of the immune system

Gabrilovich, Dmitry I., Nagaraj, Srinivas·2009·Nature Reviews Immunology

Cited by (1,052)

Items 801–900 of 1,052

  1. Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency
    Antero Salminen, Kai Kaarniranta, Anu Kauppinen · 2019 · Cellular and Molecular Life Sciences
  2. Reactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion
    Andromachi Kotsafti, Marco Scarpa, Ignazio Castagliuolo, Melania Scarpa · 2020 · Cancers
  3. Expansion of Monocytic Myeloid-Derived Suppressor Cells Dampens T Cell Function in HIV-1-Seropositive Individuals
    Aiping Qin, Weiping Cai, Ting Shuang Pan, Kang Wu, Qiong Yang, Nina Wang, Yufeng Liu, Dehong Yan, Fengyu Hu, Pengle Guo et al. · 2012 · Journal of Virology
  4. The bone-marrow niche in MDS and MGUS: implications for AML and MM
    Irene M. Ghobrial, Alexandre Detappe, Kenneth Carl Anderson, David P. Steensma · 2018 · Nature Reviews Clinical Oncology
  5. Targeted contrast agents and activatable probes for photoacoustic imaging of cancer
    Zhenxiang Zhao, Chelsea B. Swartchick, Jefferson Chan · 2022 · Chemical Society Reviews
  6. Mechanisms underlying immunosuppression by regulatory cells
    Oliver Goldmann, Obiageli Vivian Nwofor, Qian Chen, Eva Medina · 2024 · Frontiers in Immunology
  7. Blockade of A2b Adenosine Receptor Reduces Tumor Growth and Immune Suppression Mediated by Myeloid-Derived Suppressor Cells in a Mouse Model of Melanoma
    Raffaella Iannone, Lucio Miele, Piera Maiolino, Aldo Pinto, Silvana Morello · 2013 · Neoplasia
  8. Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction
    Paul C. McDonald, Shawn C. Chafe, Shoukat Dedhar · 2016 · Frontiers in Cell and Developmental Biology
  9. Lysyl Oxidase–like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer
    Fernando Salvador, Alberto Lancina Martín, Celia López‐Menéndez, Gema Moreno‐Bueno, Vanesa Santos, Alberto Vázquez-Naharro, Patricia G. Santamarı́a, Saleta Morales, Pierre R. Dubus, Laura Muinelo‐Romay et al. · 2017 · Cancer Research
  10. Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy
    Thibault Le Bourgeois, Laura Strauss, Halil‐Ibrahim Aksoylar, Saeed Daneshmandi, Pankaj Seth, Nikolaos Patsoukis, Vassiliki A. Boussiotis · 2018 · Frontiers in Oncology
  11. Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib
    Yang Yang, Mayu Sun, Wenbo Yao, Feng Wang, Xiaoguang Li, Wei Wang, Jingquan Li, Zhihu Gao, Lin Qiu, Rongli You et al. · 2020 · Journal for ImmunoTherapy of Cancer
  12. Interleukin-10 production by myeloid-derived suppressor cells contributes to bacterial persistence during Staphylococcus aureus orthopedic biofilm infection
    Cortney E. Heim, Debbie Vidlak, Tammy Kielian · 2015 · Journal of Leukocyte Biology
  13. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells
    Thomas Vollbrecht, Renate Stirner, Amanda Tufman, Julia Roider, Rudolf Maria Huber, Johannes Richard Bogner, Andreas Lechner, Carole Bourquin, Rika Draenert · 2012 · AIDS
  14. Improving cancer immunotherapy by targeting tumor-induced immune suppression
    Trina J. Stewart, Mark John Smyth · 2011 · Cancer and Metastasis Reviews
  15. Phase I Study of Random Healthy Donor–Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors
    Yaewon Yang, Okjae Lim, Tae Min Kim, Yong‐Oon Ahn, Hana Choi, Hyejin Chung, Bokyung Min, Jung Hyun Her, Sungyoo Cho, Bhumsuk Keam et al. · 2016 · Cancer Immunology Research
  16. Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer
    Takanori Kitamura, Dahlia Doughty-Shenton, Luca Cassetta, Stamatina Fragkogianni, Demi Brownlie, Yu Kato, Neil O. Carragher, Jeffrey W. Pollard · 2018 · Frontiers in Immunology
  17. Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer
    Fan Feng, Gaozan Zheng, Qiao Wang, Shushang Liu, Zhen Liu, Guanghui Xu, Fei Wang, Man Guo, Xiao Lian, Hongwei Zhang · 2018 · BMC Gastroenterology
  18. Activation of immunosuppressive network in the aging process
    Antero Salminen · 2019 · Ageing Research Reviews
  19. The Influence of Tumor Microenvironment on Immune Escape of Melanoma
    Aleksandra Simiczyjew, Ewelina Dratkiewicz, Justyna Mazurkiewicz, Marcin Ziętek, Rafał Matkowski, Dorota Nowak · 2020 · International Journal of Molecular Sciences
  20. Single‐Cell Transcriptome Profiling Reveals Multicellular Ecosystem of Nucleus Pulposus during Degeneration Progression
    Ji Tu, Wentian Li, Sidong Yang, Pengyi Yang, Yan Qi, Shenyu Wang, Kaitao Lai, Xupeng Bai, Cenhao Wu, Wenyuan Ding et al. · 2021 · Advanced Science
  21. Colorectal cancer immunotherapy-Recent progress and future directions
    Wen Zhao, Lujia Jin, Peng Chen, Dingchang Li, Wenxing Gao, Guanglong Dong · 2022 · Cancer Letters
  22. Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap
    Evgeniy B. Eruslanov, Sunil Kumar Singhal, Steven Μ. Albelda · 2017 · Trends in cancer
  23. IL-12 Promotes Myeloid-Derived Suppressor Cell Recruitment and Bacterial Persistence during Staphylococcus aureus Orthopedic Implant Infection
    Cortney E. Heim, Debbie Vidlak, Tyler D. Scherr, Curtis Wayne Hartman, Kevin L. Garvin, Tammy Kielian · 2015 · The Journal of Immunology
  24. Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes
    Baisakhi Raychaudhuri, Patricia A. Rayman, Pengjing Huang, Matthew M. Grabowski, Dolores Hambardzumyan, James Harold Finke, Michael A. Vogelbaum · 2015 · Journal of Neuro-Oncology
  25. Tumor-Specific Cytotoxic T Cells Are Crucial for Efficacy of Immunomodulatory Antibodies in Patients with Lung Cancer
    Joachim G.J.V. Aerts, Joost P. Hegmans · 2013 · Cancer Research
  26. Phosphatidylserine-Targeting Antibody Induces M1 Macrophage Polarization and Promotes Myeloid-Derived Suppressor Cell Differentiation
    Yi Yin, Xianming Huang, Kristi D. Lynn, Philip E. Thorpe · 2013 · Cancer Immunology Research
  27. Immunotherapy in sepsis - brake or accelerate?
    Folkert Steinhagen, Susanne V. Schmidt, Jens‐Christian Schewe, Konrad Peukert, Dennis M. Klinman, Christian Bode · 2020 · Pharmacology & Therapeutics
  28. The multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities
    Yu Sun, Xia Wang, Tianwei Liu, Xiaoyan Zhu, Xudong Pan · 2022 · Cell & Bioscience
  29. The Yin-Yang of Tumor-Associated Neutrophils
    Alberto Mantovani · 2009 · Cancer Cell
  30. Endotoxin-Induced Myeloid-Derived Suppressor Cells Inhibit Alloimmune Responses via Heme Oxygenase-1
    Virginie De Wilde, Nicolas Van Rompaey, Marcelo Hill, Jean‐François Lebrun, Philippe H. Lemaitre, Frédéric Lhomme, Carole Kubjak, Benoît Vokaer, Guillaume Oldenhove, Louis‐Marie Charbonnier et al. · 2009 · American Journal of Transplantation
  31. Clinical Perspectives on Targeting of Myeloid Derived Suppressor Cells in the Treatment of Cancer
    Yana George Najjar, James Harold Finke · 2013 · Frontiers in Oncology
  32. Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma
    Ahmad A. Tarhini, John Cherian, Stergios J. Moschos, Hussein A. Tawbi, Yongli Shuai, William E. Gooding, Cindy Sander, John M. Kirkwood · 2011 · Journal of Clinical Oncology
  33. Lung Cancer Subtypes Generate Unique Immune Responses
    Stephanie Busch, Mark L. Hanke, Julia Kargl, Heather E. Metz, David P MacPherson, A. McGarry Houghton · 2016 · The Journal of Immunology
  34. Rational design of a minimalist nanoplatform to maximize immunotherapeutic efficacy: Four birds with one stone
    Shiyao Zhou, Qi Shang, Ningning Wang, Qian Li, Aixin Song, Yuxia Luan · 2020 · Journal of Controlled Release
  35. The Tumor Microenvironment: A Pitch for Multiple Players
    Schiavoni, Giovanna, Gabriele, Lucia, Mattei, Fabrizio · 2013 · Frontiers in Oncology
  36. Targeting immune suppressing myeloid-derived suppressor cells in oncology
    Johnny Kao, Eric C. Ko, Samuel G. Eisenstein, Andrew Gregory Sikora, Shibo Fu, Shu‐Hsia Chen · 2010 · Critical Reviews in Oncology/Hematology
  37. Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation
    Lisha Ai, Shidai Mu, Chunyan Sun, Fengjuan Fan, Han Yan, You Qin, Guohui Cui, Yadan Wang, Tao Guo, Heng Mei et al. · 2019 · Molecular Cancer
  38. Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice
    Dinesh Chandra, Arthee Jahangir, Wilber Quispe‐Tintaya, Mark H. Einstein, Claudia Gravekamp · 2013 · British Journal of Cancer
  39. Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
    Rikke Holmgaard, Dmitriy Zamarin, Alexander M. Lesokhin, Taha Merghoub, Jedd D. Wolchok · 2016 · EBioMedicine
  40. Primary and acquired resistance to PD-1/PD-L1 blockade in cancer treatment
    Qiaohong Wang, Xia Wu · 2017 · International Immunopharmacology
  41. The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies
    Constantin N. Baxevanis, Sotirios P. Fortis, Sonia A. Perez · 2019 · Seminars in Cancer Biology
  42. Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma
    Cristina Pérez, Cirino Botta, Aintzane Zabaleta, Noemí Puig, María‐Teresa Cedena, Ibai Goicoechea, Daniel Alameda, Edurne San José‐Eneriz, Juana Merino, Paula Rodríguez‐Otero et al. · 2020 · Blood
  43. Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors
    Aohan Hou, Kaiyu Hou, Qiubo Huang, Yujie Lei, Wan-Ling Chen · 2020 · Frontiers in Immunology
  44. The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer
    Mahiru Kawano, Seiji Mabuchi, Yuri Matsumoto, Tomoyuki Sasano, Ryoko Takahashi, Hiromasa Kuroda, Katsumi Kozasa, Kae Hashimoto, Aki Isobe, Kenjiro Sawada et al. · 2015 · Scientific Reports
  45. Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells
    Zibing Wang, Brian G. Till, Quanli Gao · 2017 · OncoImmunology
  46. Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections
    Anca Dorhoi, Nelita du Plessis · 2018 · Frontiers in Immunology
  47. Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients
    Kimberly Rae Jordan, Rodabe Navroze Amaria, Oscar Ramirez, Eryn Callihan, Dexiang Gao, Michelle Borakove, Elizabeth Manthey, Virginia F. Borges, Martin D. McCarter · 2013 · Cancer Immunology Immunotherapy
  48. PGE2-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells
    Nataša Obermajer, Jeffrey L. Wong, Robert P. Edwards, Kunle O. Odunsi, Kirsten B. Moysich, Paweł Kaliński · 2012 · Immunological Investigations
  49. Implantable Synthetic Immune Niche for Spatiotemporal Modulation of Tumor‐Derived Immunosuppression and Systemic Antitumor Immunity: Postoperative Immunotherapy
    Hathaichanok Phuengkham, Chanyoung Song, Soong Ho Um, Yong Taik Lim · 2018 · Advanced Materials
  50. Tumor Neovascularization and Developments in Therapeutics
    Yuki Katayama, Junji Uchino, Yusuke Chihara, Nobuyo Tamiya, Yoshiko Kaneko, Tadaaki Yamada, Koichi Takayama · 2019 · Cancers
  51. Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review
    Enakshi Sivasudhan, NEIL W. BLAKE, Zhi-Liang Lu, Jia Meng, Rong Rong · 2022 · Cells
  52. Cancer Immunoediting in the Era of Immuno-oncology
    Matthew M. Gubin, Matthew D. Vesely · 2022 · Clinical Cancer Research
  53. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response
    Małgorzata Sielska, Piotr Przanowski, Bartosz Wylot, Konrad R. Gabrusiewicz, Marta Maleszewska, Magdalena Kijewska, Małgorzata Zawadzka, Joanna Kucharska, Katyayni Vinnakota, Helmut Kettenmann et al. · 2013 · The Journal of Pathology
  54. Molecular Pathways: Tumor-Infiltrating Myeloid Cells and Reactive Oxygen Species in Regulation of Tumor Microenvironment
    Tangying Lu, Dmitry I. Gabrilovich · 2012 · Clinical Cancer Research
  55. Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes
    Karl E. Carlström, Ewoud Ewing, Mathias Granqvist, Alexandra Gyllenberg, Shahin Aeinehband, Sara Lind Enoksson, Antonio Checa, Tejaswi V. S. Badam, Jesse Huang, David Gómez-Cabrero et al. · 2019 · Nature Communications
  56. Environmental, Microbiological, and Immunological Features of Bacterial Biofilms Associated with Implanted Medical Devices
    Marina Caldara, Cristina Belgiovine, Eleonora Secchi, Roberto Rusconi · 2022 · Clinical Microbiology Reviews
  57. Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
    Ilia N. Buhtoiarov, Paul M. Sondel, Jon M. Wigginton, Tatiana N. Buhtoiarova, Eric M. Yanke, David A. Mahvi, Alexander L. Rakhmilevich · 2010 · Immunology
  58. Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells<i>in vitro</i>in a TLR4-independent manner
    Michels, Tillmann, Shurin, Galina V., Naiditch, Hiam, Sevko, Alexandra, Umansky, Viktor, Shurin, Michael R. · 2012 · Journal of Immunotoxicology
  59. Tumor Microenvironment and Myeloid-Derived Suppressor Cells
    Viktor Umansky, Alexandra Sevko · 2012 · Cancer Microenvironment
  60. Chemotherapeutic Targeting of Cancer-Induced Immunosuppressive Cells
    Darya Alizadeh, Nicolas Larmonier · 2014 · Cancer Research
  61. Myeloid-Derived Suppressor Cells Are Controlled by Regulatory T Cells via TGF-β during Murine Colitis
    Chorong Lee, Yewon Kwak, Taewoo Yang, Jung Hyun Han, Sangheon Park, Michael B. Ye, Wongeun Lee, Kyu-Young Sim, Jung‐Ah Kang, Yong‐Chul Kim et al. · 2016 · Cell Reports
  62. Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress
    Meriem Hasmim, Yosra Messai, Linda Ziani, Jérôme Thiery, Jean-Henri Bouhris, Muhammad Zaeem Noman, Salem Chouaı̈b · 2015 · Frontiers in Immunology
  63. Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities
    Shanmugasundaram Ganapathy‐Kanniappan · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  64. The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
    Galaxia M. Rodriguez, Kristianne J.C. Galpin, Curtis W. McCloskey, Barbara C. Vanderhyden · 2018 · Cancers
  65. Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines
    Afifaa Butt, Kingston H. G. Mills · 2013 · Oncogene
  66. Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction
    Sabrina Danilin, Alyssa R. Merkel, Joshua Johnson, Rachelle W. Johnson, James Edwards, Julie A. Rhoades Sterling · 2012 · OncoImmunology
  67. The role of IL-6 in the radiation response of prostate cancer
    Chun‐Te Wu, Miao‐Fen Chen, Wen‐Cheng Chen, Ching‐Chuan Hsieh · 2013 · Radiation Oncology
  68. The diversity of circulating neutrophils in cancer
    Inbal Mishalian, Zvi Granot, Zvi Gregorio Fridlender · 2016 · Immunobiology
  69. A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway
    Hao Xue, Guang Yuan, Xing Guo, Qinglin Liu, Jinsen Zhang, Xiao Chan Gao, Xiaofan Guo, Shugang Xu, Tong Li, Qianqian Shao et al. · 2016 · Autophagy
  70. Polyamines and Kynurenines at the Intersection of Immune Modulation
    Elisa Proietti, Sofia Rossini, Ursula Grohmann, Giada Mondanelli · 2020 · Trends in Immunology
  71. Tumor Microenvironment: A New Treatment Target for Cancer
    Ming‐Ju Tsai, Wei‐An Chang, Ming‐Shyan Huang, Po‐Lin Kuo · 2014 · ISRN Biochemistry
  72. Multipotent Human Mesenchymal Stromal Cells Mediate Expansion of Myeloid-Derived Suppressor Cells via Hepatocyte Growth Factor/c-Met and STAT3
    Betty Linju Yen, Ming‐Shyen Yen, Pei‐Ju Hsu, Ko‐Jiunn Liu, Chia-Jen Wang, Chyi‐Huey Bai, Huey‐Kang Sytwu · 2013 · Stem Cell Reports
  73. Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma
    Yumeng Mao, Nina Eißler, Katarina Le Blanc, John Inge Johnsen, Per Kogner, Rolf W. Kiessling · 2016 · Clinical Cancer Research
  74. Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer
    Shintaro Takeuchi, Muhammad Baghdadi, Takahiro Tsuchikawa, Haruka Wada, Toru Nakamura, Hirotake Abe, Sayaka Nakanishi, Yuu Usui, Kohtaro Higuchi, Mizuna Takahashi et al. · 2015 · Cancer Research
  75. Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma.
    Hong-li Sun, Xin Min ZHOU, Yifeng Xue, Ke Wang, Yunfeng Shen, Jingjue Mao, Hongfeng Guo, Zongning Miao · 2012 · Europe PMC (PubMed Central)
  76. Consensus nomenclature for CD8+T cell phenotypes in cancer
    Lionel Apétoh, Mark John Smyth, Charles G. Drake, Jean‐Pierre Abastado, Ron N. Apte, Maha Ayyoub, Jean‐Yves Blay, Marc Bonneville, Lisa Helene Butterfield, Anne Caignard et al. · 2015 · OncoImmunology
  77. Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
    Shweta Joshi, Andrew B. Sharabi · 2022 · Pharmacology & Therapeutics
  78. The Role of Tumor Microenvironment in Cancer Immunotherapy
    Frankel, Timothy, Lanfranca, Mirna Perusina, Zou, Weiping · 2017 · Advances in Experimental Medicine and Biology
  79. S100A9 Interaction with TLR4 Promotes Tumor Growth
    Eva Källberg, Thomas Vogl, David Liberg, ANDERS G. OLSSON, Per Björk, Pernilla Wikström, Anders R. J. Bergh, Johannes Roth, Fredrik Ivars, Tomas Leanderson · 2012 · PLoS ONE
  80. IL-17RA Signaling Reduces Inflammation and Mortality during Trypanosoma cruzi Infection by Recruiting Suppressive IL-10-Producing Neutrophils
    Jimena Tosello, Maria Carolina Amezcua Vesely, Daniela Andrea Bermejo, Maria Cecilia Ramello, Carolina Lucía Montes, Hugo Cejas, Adriana Gruppi, Eva V. Acosta Rodríguez · 2012 · PLoS Pathogens
  81. Myeloid‐derived suppressor cells in inflammation: Uncovering cell subsets with enhanced immunosuppressive functions
    Vincenzo Bronte · 2009 · European Journal of Immunology
  82. The Intersection of Immune Responses, Microbiota, and Pathogenesis in Giardiasis
    Marc Y. Fink, Steven M. Singer · 2017 · Trends in Parasitology
  83. How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions
    Annika M. Bruger, Anca Dorhoi, Güneş Esendağlı, Katarzyna Barczyk‐Kahlert, Pierre van der Bruggen, Marie Lipoldová, Tomáš Perečko, Juan Francisco Santibanez, Margarida Saraiva, Jo A. Van Ginderachter et al. · 2018 · Cancer Immunology Immunotherapy
  84. IL-6: The Link Between Inflammation, Immunity and Breast Cancer
    Juan Chen, Yanghui Wei, Weiqin Yang, Qingnan Huang, Yong Chen, Kai Zeng, Jiawei Chen · 2022 · Frontiers in Oncology
  85. Strong vaccine responses during chemotherapy are associated with prolonged cancer survival
    Melief, Cornelis J. M., Welters, Marij J. P., Vergote, Ignace, Kroep, Judith R., Kenter, Gemma G., Ottevanger, Petronella B., Tjalma, Wiebren A. A., Denys, Hannelore, van Poelgeest, Mariette I. E., Nijman, Hans W. et al. · 2020 · Science Translational Medicine
  86. Complex role for the immune system in initiation and progression of pancreatic cancer
    Kristin S. Inman · 2014 · World Journal of Gastroenterology
  87. TGF-β Receptor II Loss Promotes Mammary Carcinoma Progression by Th17-Dependent Mechanisms
    Sergey V. Novitskiy, Michael W. Pickup, Agnieszka E. Gorska, Philip Owens, Anna M. Chytil, Mary E. Aakre, Huiyun Wu, Yu Shyr, Harold L. Moses · 2011 · Cancer Discovery
  88. The Nlrp3 inflammasome, IL‐1β, and neutrophil recruitment are required for susceptibility to a nonhealing strain of Leishmania major in C57BL/6 mice
    Mélanie Charmoy, Benjamin P. Hurrell, Audrey Romano, Sang Hun Lee, Flávia Lima Ribeiro-Gomes, Nicolas Riteau, Katrin D. Mayer-Barber, Fabienne Tacchini‐Cottier, David L. Sacks · 2015 · European Journal of Immunology
  89. Immune regulatory network in successful pregnancy and reproductive failures
    Mahnaz Ghaebi, Mohammad Nouri, Aliyeh Ghasemzadeh, Laya Farzadi, Farhad Jadidi‐Niaragh, Majid Ahmadi, Mehdi Yousefi · 2017 · Biomedicine & Pharmacotherapy
  90. Fusobacterium and Colorectal Cancer
    Ziwei Zhou, Jiewen Chen, Herui Yao, Hai Hu · 2018 · Frontiers in Oncology
  91. Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine
    Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani, Ammar Khaled Daoud · 2020 · Open Biology
  92. Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
    Yi Wang, Kai Conrad Cecil Johnson, Margaret Elena Gatti-Mays, Zihai Li · 2022 · Journal of Hematology & Oncology
  93. Extracellular vesicles and particles impact the systemic landscape of cancer
    Serena Lucotti, Candia M. Kenific, Haiying Zhang, David C. Lyden · 2022 · The EMBO Journal
  94. Cutaneous Innate Immune Sensing of Toll-like Receptor 2-6 Ligands Suppresses T Cell Immunity by Inducing Myeloid-Derived Suppressor Cells
    Yuliya Skabytska, Florian Wölbing, Claudia Günther, Martin Köberle, Susanne Kaesler, Ko-Ming Chen, Emmanuella Guenova, Doruk Demircioglu, Wolfgang E. Kempf, Thomas Volz et al. · 2014 · Immunity
  95. Chronic but Not Acute Virus Infection Induces Sustained Expansion of Myeloid Suppressor Cell Numbers that Inhibit Viral-Specific T Cell Immunity
    Brian A. Norris, Luke S. Uebelhoer, Helder Imoto Nakaya, Aryn A. Price, Arash Grakoui, Bali Pulendran · 2013 · Immunity
  96. Immunosuppressive Tumor Microenvironment in Cervical Cancer Patients
    Sytse J. Piersma · 2011 · Cancer Microenvironment
  97. MDSC in autoimmunity
    James G. Cripps, James D. Gorham · 2011 · International Immunopharmacology
  98. Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment
    Yan Ru Cui, Gang Guo · 2016 · International Journal of Molecular Sciences
  99. Dynamic responses of the haematopoietic stem cell niche to diverse stresses
    Antoniana Batsivari, Myriam Luydmila Rachelle Haltalli, Diana Passaro, Constandina Pospori, Cristina Lo Celso, Dominique A. Bonnet · 2020 · Nature Cell Biology
  100. Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours
    Kamilla J. A. Bigos, Conrado Guerrero Quiles, Sapna Lunj, Danielle J. Smith, Mechthild Krause, Esther G.C. Troost, Catharine West, Peter Hoskin, Ananya Choudhury · 2024 · Frontiers in Oncology